Trial Profile
A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant Women.
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Didanosine (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics
- 11 Oct 2005 New trial record.